Eli Lilly to integrate Welldoc’s BlueStar app capabilities into its connected insulin solutions
The two companies will collaborate to create a new version of the BlueStar insulin management solution that integrates insulin data for Lilly insulins.
Welldoc’s chronic condition platform expanded to include behavioral health
The new offering complements existing programs for diabetes, hypertension, heart failure and diabetes prevention.
Welldoc, Redox team-up to optimize provider interaction with chronic disease management platform
By ensuring bidirectional integration with EHRs and insights available at the point of care, the partnership will help optimize clinical decision support.
WellDoc validates potential of BlueStar to reduce healthcare costs
The company worked with Truven Health Analytics to show that BlueStar can save on average a range of $254 to $271 per user per month.
WellDoc’s diabetes management app BlueStar C coming to Samsung Health
BlueStar C is a diabetes health tool designed to aid individuals living with diabetes in managing their chronic condition.
WellDoc, HTAA team-up to address diabetes in trucking industry
WellDoc has also unveiled its consumer diabetes health app, BlueStar C, to aid individuals living with diabetes manage their chronic condition.
Non-prescription version of WellDoc’s BlueStar Digital Therapeutic gets FDA 510(k) clearance
The non-prescription version will have all the first-in-class features of BlueStar® Rx apart from an insulin calculator.
WellDoc, AADE team-up to enhance the BlueStar Digital Therapeutic Platform
This is the first time AADE has partnered with an organization to provide its curriculum in a consumer-friendly digital format.
LifeScan, WellDoc team-up to advance mobile care for Type 2 diabetes patients
The two companies will integrate LifeScan's OneTouch Verio Flex blood glucose monitoring system with WellDoc's BlueStar diabetes management platform.
WellDoc gets $22M Series B for its diabetes management solution
The company will use the funds to accelerate adoption of BlueStar mobile prescription therapy for adults living with type 2 diabetes.